The prophylactic use of G-CSF contributes to successful remission from breast cancer by maintaining ≥ 85% of the planned relative dose intensity (RDI) of chemo-medications during chemotherapy [14,15,16,17]. Here, CSF3 is linked to breast carcinoma.